期刊
CHEMICAL BIOLOGY & DRUG DESIGN
卷 85, 期 1, 页码 43-55出版社
WILEY
DOI: 10.1111/cbdd.12430
关键词
biological screening; chemical biology; structure-based drug design; therapeutic target
资金
- Kelvin-Smith studentship by University of Glasgow
There is an urgent requirement for new anti-infective compounds that can be used to prevent or treat bacterial pathogens. In particular, Gram-negative pathogens, which are most commonly associated with hospital-acquired infections, are of major concern. In this review, we cover recent developments in the screening and testing of new anti-infective compounds that interfere with aspects of bacterial pathogenicity. This so-called antivirulence approach is very different to traditional antibiotic development and testing. Moreover, antivirulence compounds vary considerably in their chemical structures, ranging from small compounds to large natural products. The challenge of understanding the precise mechanism of action of any such compound is also highlighted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据